Back to Journals » Therapeutics and Clinical Risk Management » Volume 19

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Total article views   HTML views PDF downloads Totals
14,644 Dovepress* 8,552+ 123 8,675
PubMed Central* 6,092 544 6,636
Totals 14,644 667 15,311
*Since 2 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
299 1 0 0 142 156

View citations on PubMed Central and Google Scholar